Related by context. All words. (Click for frequent words.) 80 ArQule Kinase Inhibitor Platform 80 AKIP ™ 70 product platforms AZX# 68 platform HDL Mimetic 68 Nasdaq XTLB 68 pralatrexate injection folate analogue 67 Nasdaq LXRX biopharmaceutical 67 FOLOTYN ® 67 OTCBB QTXB 67 NASDAQ MNKD focuses 67 novel RNAi therapeutics 66 OTCBB PYTO 66 Therapeutic Competitors companiesandmarkets.com adEgemonye 66 Board LWLG technology 66 developing calcitonin 66 NASDAQ AVEO biopharmaceutical 66 OTCQB CTIX 65 TRANSDUR ™ 65 OTC Bulletin Board LWLG 65 ATRA IV 65 OR REVISE ANY FORWARD 65 Telik logo TELINTRA 65 novel peptides 65 Inc. AMEX YMI 65 HuCAL PLATINUM ® CysDisplay 65 CRMD pharmaceutical 65 ThermoDox ® clinical 65 CysDisplay R 65 Licenses Novel 65 candidates Azedra TM 65 Selective Electrochemical Tumor Ablation 65 Ligand proprietary 65 Solazed TM 65 Presents Preclinical Data 65 visit http:/www.mannkindcorp.com 64 Kosan dependence 64 proprietary PEGylation 64 Locked Nucleic Acid 64 DARA logo 64 commercializing anti infective 64 Nasdaq MNKD focused 64 optical biosensors 64 MDRNA proprietary 64 Announces Poster Presentations 64 website www.competitivetech.net 64 Reports Preclinical Data 64 AMEX REX 64 Completes Patient Enrollment 64 OTCBB CHKT 64 website www.lipidsciences.com 64 CONTAIN FORWARD LOOKING STATEMENTS 64 rusalatide acetate 64 technology Parthenogenesis 64 Nasdaq IDRA today 64 TSX CTI 64 novel kinase inhibitors 64 Initiates Phase II 64 RealPennies.com RealPennies.com 63 Pharma Merck Serono 63 TRANSDUR ® 63 Therapeutic Competitors Companies 63 programs visit http:/www.bionovo.com 63 novel anti infective 63 TSX VENTURE DMA 63 SPL# Gel vaginal microbicide 63 AAG geldanamycin analog 63 Announce License Agreement 63 lead molecular radiotherapeutic 63 novel therapeutic antibodies 63 blood serum biomarkers 63 Eg5 kinesin spindle 63 Receives Milestone Payment 63 Presents Preclinical 63 PRNewswire FirstCall Neurogen 63 HuCAL GOLD R 63 Initiates Enrollment 63 www.ucb group.com 63 TM Aganocide 63 DiLA2 63 molecular chaperone regulation 63 small molecule agonists 63 Frankfurt XMP 63 TSX VIR 63 PDGFR B 63 Aphton Corporation 63 Nasdaq HALO biopharmaceutical 63 ARRY # 63 pentadentate logo R 63 THAT ARE SUBJECT TO 63 silicon carbide SiC gallium 63 Company Nasdaq RGDX 63 CONTAINS FORWARD LOOKING STATEMENTS 63 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 63 ELADUR ™ 63 OTCBB IBPM 62 NovaDel oral spray 62 EOD data 62 PURPOSE OF SAFE HARBOR 62 OF SECTION #A 62 FOLLOWED BY OR 62 QMDT 62 Nasdaq TARG 62 developing Zerenex TM 62 including thyroiditis RA 62 Inc. Nasdaq OXGN 62 TSX GIX FRANKFURT GF6 62 Nasdaq RGDX 62 MPH AMEX 62 OTCBB HXBM developer 62 Inc Therapeutic Competitors 62 By THERESA CAMPBELL 62 NYSE Amex PBTH 62 Initiates Clinical Trial 62 IXSBF 62 CYP#A# CYP#D# 62 tranquilizers diazepam 62 Chrysalin r rusalatide acetate 62 introduced NEUGENE 62 Nasdaq RXII 62 Epeius Biotechnologies Corporation 62 OF DESCRIPTION GENUINENESS 62 DNA methyltransferase inhibitors 62 STATEMENT WHEN IT BECOMES 62 TO IDENTIFY SUCH FORWARD 62 ARE NOT INDICATIVE OF 62 http:/www.pharmacopeia.com 62 internet website www.mcmoran.com 62 Files IND 62 Antigen Express website 62 www.vioquestpharm.com 62 oncolytic virus therapies 62 ACCORDINGLY READERS SHOULD NOT 62 Avian Transgenic Technology 62 TSX VENTURE GAP 62 R MSCRAMM 62 please visit www.advaxis.com 62 THAT COULD CAUSE ACTUAL 62 ABL inhibitor 62 Shrink OTC Bulletin 62 OTCBB FCSC 62 Provectus Pharmaceuticals specializes 62 Cephalon GlaxoSmithKline 62 4SC AG ISIN DE# 62 Corp. www.anavex.com 62 candidate CRLX# 62 www.pranabio.com 62 DG# compounds targeting 62 TSX PEZ OTCBB 62 OTCBB IGXT 62 Nasdaq PARD 62 THE REPORTING 62 OR OTHER EXPECTATIONS IMPLIED 62 AS ESTIMATE ANTICIPATE BELIEVE 62 subsidiaries InnerCool Therapies 62 Colaris Colaris AP 62 PLAN OR EXPECT 62 SAFE HARBOR PROVISIONS OF 62 Xcytrin R 62 DATE HEREOF AND 61 THE MERGER CAREFULLY AND 61 Neurogen Corporation 61 specific lectin receptors 61 please visit www.medicinova.com 61 personalized cellular immunotherapy 61 PNP inhibitor 61 commercializing therapeutic 61 Announces Dosing 61 Presents Positive 61 peptidic compound 61 MATERIALLY FROM ANY FUTURE 61 HCV NS3 protease 61 ZFN TM 61 delights O'Dor 61 peptide peptide mimetic 61 dihydrochloride Tablets 61 Initiates Dosing 61 THE COMPANY TO BE 61 PROVISIONS OF THE PRIVATE 61 RapMAT ® 61 SIMILAR EXPRESSIONS ARE INTENDED 61 QuantRx Biomedical Corporation 61 'S FUTURE PLANS 61 BELIEFS PLANS EXPECTATIONS OR 61 Factor Receptor 61 Italy coul 61 GVAX ® 61 WHICH ARE NOT PURELY 61 WEB OF SCIENCE 61 OTCBB CHKT biotechnology 61 investigational humanized monoclonal antibody 61 AMEX ISV 61 MAY CONTAIN FORWARD LOOKING 61 lipid particles SNALP 61 Veronate R 61 를 다운 인터넷 에서 61 biomarkers predictive 61 synthetic cannabinoid compounds 61 G Protein Coupled 61 coronary stent merged 61 PAST RESULTS 61 THAT INCLUDE SUCH WORDS 61 RON Notch 61 HIV AIDS neuropathic pain 61 Inc. NASDAQ IDMI 61 MONSTERSTOX.COM Monsterstox.com 61 www.Power3Medical.com 61 LWLG 61 NASDAQ SNTA biopharmaceutical 61 RELIANCE UPON ANY FORWARD 61 http:/www.unitedfamilyhospitals.com 61 Ibis T# TM 61 enhance ApoA 61 INDICATED LOWER 61 http:/www.unigene.com 61 factor receptor FGFR 61 Genentech Wyeth Pharmaceuticals 61 OTCBB SLAT 61 ALN PCS 61 Adnectin 61 www.appliednanotech.net 61 INTENDS PLANS BELIEVES SEEKS 61 RNA interference RNAi therapeutics 61 Sangamo BioSciences Announces 61 WITHDRAW ANY ITEM 61 JAK2 Inhibitor 61 Nasdaq FOLD 61 Personalized Immunotherapy 61 OTCBB VSPC 61 Inc. Nasdaq IMGN 61 affiliate Evogene Ltd. TASE 61 #/#/# Cytokinetics Incorporated 61 NASDAQ EPIX biopharmaceutical 61 Nasdaq IDRA 61 STATEMENTS WITHIN THE MEANING 61 renin inhibition promising 61 rxRNA 61 AND ORAL STATEMENTS MADE 61 www.durect.com 61 NuMimetic TM 61 REPORTS FILED WITH 61 subsidiaries visit http:/www.apricusbio.com 61 Nasdaq AEGR 61 please visit http:/www.vandapharma.com 61 Phase 2b Clinical Trial 61 MSCRAMM ® 61 AFFECT MICROSEMI 'S 61 product candidate Lpathomab 61 regarding Aethlon Medical 61 biocompatibility capabilities 61 OTC BB PVCT 61 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 61 Inc. www.transgenomic.com 61 BY REPRESENTATIVES OF 61 Aganocide R 60 visit www.novabaypharma.com 60 www.vicortech.com 60 CONTROL WHICH MAY CAUSE 60 investigational pan BCR 60 biologically validated targets 60 ATTRIBUTING UNDUE CERTAINTY OR 60 Nasdaq IMGN 60 Cardium Therapeutics TM 60 INCLUDE ANY STATEMENTS REGARDING 60 Inc. http:/www.endocare.com 60 include ClindaReach TM 60 NeutroPhase TM 60 AREAS AFFECTED 60 BioFocus DPI Galapagos 60 About Positron Positron 60 UNCERTAINTIES OR OTHER 60 http:/www.tripos.com 60 AND TO REOFFER 60 THE COMPANY UNDERTAKES NO 60 Dyax logo 60 Inc. ProMetic www.prometic.com 60 CDK cyclin dependent 60 BayStreet.ca Research Alert 60 INVOLVE RISKS AND UNCERTAINTIES 60 ELADUR TM 60 Visit CTT 60 Completes Enrollment 60 kidney urologic 60 OF THE SUBSTANCE 60 JAK1 60 Nasdaq RXII recognized 60 derivatives Radilex TM 60 molecular imaging radiopharmaceutical 60 IN SUCH FORWARD 60 certain protein tyrosine 60 TKB# 60 OTCBB IMNR 60 ALN TTR 60 agonistic human 60 www.syntapharma.com 60 tests miRview ™ 60 AVXL 60 MAY INCLUDE FORWARD LOOKING 60 By MARK TODD 60 PLACE UNDUE RELIANCE ON 60 anionic backbone 60 LOOKING STATEMENTS TO REFLECT 60 Transdel Pharmaceuticals Inc. 60 NYSE Amex PTN 60 Nasdaq VNDA 60 sarcoma melanoma 60 Fero Industries Inc. 60 Response Genetics Inc. 60 Alfacell proprietary ribonuclease 60 Zemiva TM Trofex TM 60 Aradigm Logo 60 OBLIGATION TO REVISE OR 60 deCODE chemistry 60 Nasdaq CYTR biopharmaceutical 60 Tissue Repair Company 60 CEO www.squeezetrigger.com +#-#-#-# 60 Inc. www.sanuwave.com 60 OF VARIOUS PROJECT 60 please visit www.dyax.com 60 NasdaqCM PSTI DAX PJT 60 Nasdaq HALO 60 CYT# potent vascular disrupting 60 THESE STATEMENTS FOR REVISIONS 60 RESULTS TO DIFFER 60 OR SIMILAR STATEMENTS ARE 60 http:/www.ovonic.com/ 60 Abstract Accepted 60 taste modulators 60 www.sanuwave.com 60 Dinkins TE 60 XL# anticancer compounds 60 UNCERTAINTIES AND OTHER FACTORS 60 SHALL NOT CONSTITUTE AN 60 gastro intestinal inflammation 60 Barclay Hambrook P. Eng 60 Aganocide ® 60 molecular therapeutics immunotherapies 60 CoTherix logo 60 proprietary capillary aerosolization 60 NS5b 60 BY THESE FORWARD 60 IS FOR INFORMATIONAL 60 www.polymedix.com 60 DURECT proprietary 60 Alnylam Nasdaq ALNY 60 NASDAQ ABII 60 Begins Dosing 60 proprietary delipidation technologies 60 RELY UPON THIS 60 Nasdaq MYRX 60 SMA Indústria Química SA 60 www.rxipharma.com 60 RESULTS INDICATED OR IMPLIED 60 ZFNs clinical trials 60 OF LIABILITY FOR DAMAGES 60 MEMPHIS HAS ISSUED 60 Systemic Delivery 60 THOSE CONTAINED IN 60 oncolytic viruses 60 SENOMYX ANNOUNCES 60 IG HCR ;) CO 60 www.vical.com 60 accumulate preferentially 60 oral ferric iron 60 novel VDA molecule 60 acne impetigo 59 Vaccine Adjuvant 59 OBLIGATION TO UPDATE 59 please visit www.gnss.com 59 Helix BioMedix Inc. 59 Protein Expression 59 www.hanabiosciences.com 59 AcryMed technologies 59 INVESTORS SHOULD NOT 59 stable nucleic acid 59 PROLOR Biotech Inc. 59 novel proprietary KL4 59 Tumour Vascular Disrupting Agent 59 EXPRESSED OR IMPLIED 59 novel orally administered 59 website www.advbiomaterials.com 59 NYSE Amex RGN 59 Nasdaq ENMD 59 Inc. OTCBB NNAN 59 STATEMENT BECAUSE IT CONTAINS 59 SECURITIES COMMISSION OR OTHER 59 PINNACLEDIGEST.COM S PAST PERFORMANCE 59 proprietary polysaccharide 59 NASDAQ EMIS 59 THE AUCTIONEER RESERVES 59 oral ghrelin agonist 59 Myriad logo BRACAnalysis 59 PLACE UNDUE IMPORTANCE ON 59 AND ARE SUBJECT 59 NASDAQ LGND 59 biased ligand 59 UPDATE THESE FORWARD 59 Software Seapine Software 59 mitotic kinesin centromere associated 59 NYSE Alternext ULU 59 www.qiagen.com 59 Bone Augmentation Material 59 http:/www.appliedbiosystems.com/ 59 Completes Dosing 59 small molecule defensin 59 Well Infrared Photodetector 59 Cynapsus formerly 59 COX FP Reuters NCOX.PA 59 commercialize Aganocides 59 Novelos Therapeutics Inc. 59 & BOVESPA TEND3 59 please visit http:/www.atherogenics.com 59 MIND CTI LTD 59 FGFR 59 electro optic polymer 59 Namenda Memantine HCl 59 DATA ARE FORWARD 59 AND OBJECTIVES OR 59 telomerase therapeutic 59 By JAMAAL ABDUL 59 Plc Ads SHPGY 59 purinergic receptors P#X# 59 OTCBB TDLP 59 Zemiva TM 59 AND ASSUMPTIONS AND 59 OR INFORMATION 59 UNCERTAINTIES OR OTHER FACTORS 59 agonist compounds 59 NO ASSURANCE THAT 59 ALN TTR# 59 Vitamin D analogue 59 Redpoint Bio Corporation 59 www.caliperLS.com 59 INFORMATION AS 59 www.utekcorp.com 59 www.vivus.com 59 Power3 Alzheimer disease 59 5 HT6 receptor 59 non nucleoside inhibitor 59 www.cellgenesys.com 59 LIMITATION MAY NOT APPLY 59 Antigen Specific 59 Small interfering RNAs 59 HAS ATTEMPTED TO IDENTIFY 59 www.telik.com 59 developing Bicifadine serotonin 59 CAN BE IDENTIFIED BY 59 Present Preclinical Data 59 Viprovex R 59 LYON France BUSINESS WIRE 59 Pruvel TM 59 ImmuneRegen BioSciences Inc. 59 www.ziopharm.com 59 Inc. Nasdaq ONTY 59 company website www.novavax.com 59 NASDAQ SNTA 59 Alzheimer disease cognitive impairment 59 ENSL 59 Cynapsus Therapeutics Inc. 59 Inc. Nasdaq CYCC 59 NOxOUT CASCADE R 59 www.royalcaribbean.com www.celebrity.com www.pullmAhmed Hilles clan 59 MANAGEMENT 'S CURRENT BELIEFS 59 website http:/www.molecularinsight.com 59 NO ASSURANCE THAT ANY 59 Homspera TM 59 Preclinical Data 59 lead heptagonist compound 59 www.cerus.com 59 visit www.targanta.com 59 Immunicon Corporation 59 Inc. OTCBB SNWV 59 antiangiogenesis therapies 59 OTCBB NRGX 59 OTCBB CGXP 59 website http:/www.celsion.com 59 STATEMENTS CONTAINING FORWARD LOOKING 59 SHOULD BE READ 59 www.lasikplus.com 59 Enrolls First 59 developing ostarine selective 59 AB OMXS BINV 59 HER1 59 NYSE AMEX ENA 59 http:/www.celera.com 59 Inc. NASDAQ AEZS 59 PRNewswire FirstCall Nastech Pharmaceutical 59 오늘 59 www.cougarbiotechnology.com 59 Crofelemer budesonide foam 59 Submits NDA 59 www.artesmedical.com 59 Curaxin CBLC# 59 Ads NVS NVS 59 Nasdaq THLD 59 visit www.PAREXEL.com 59 FORWARD LOOKING INFORMATION WITHIN 59 g r 59 Valortim TM 59 Genaera Corporation 59 Nasdaq IDIX biopharmaceutical 59 Ferring Pharmaceuticals specializes 59 Nicolas Cage reunites 59 STOP SHOPPING FOR 59 novel peptide 59 OR ACHIEVEMENTS IMPLIED 59 AND RECOMMENDED ACTIONS 59 proprietary bioresorbable polymer 59 Village inc 59 microRNA therapeutics 59 Nasdaq OMER biopharmaceutical 59 please visit www.PositiveIDCorp.com 59 monocytogenes Listeria vaccines 59 OTCBB IMUC 59 Urigen Pharmaceuticals Inc. 59 fungal infections malaria tuberculosis 59 virus HCV protease inhibitor 59 developing chemokine 59 OTCBB OHRP 59 tests miRview TM 59 MIMTF 59 novel immunotherapies 59 Fibrocell Science Inc. 59 Introduce Next Generation 59 Inc. www.micromet inc.com 59 Agios Pharmaceuticals 59 BEAMS STONE AND WOODWORK 59 SIRT1 activators 59 humanized anti 58 2 methoxyestradiol 58 DOS# 58 OTCBB JMAR leading 58 isoform selective 58 RELIANCE UPON FORWARD LOOKING 58 PDX pralatrexate 58 Email @ sra 58 website www.celsion.com 58 Nasdaq ENDO 58 Omeros Corporation 58 StromaCel Inc. 58 Inc. OTCBB ECTE 58 Receptors GPCRs 58 Alvine Pharmaceuticals 58 AND OTHER RISKS AND 58 modified glutathione analog 58 PI3K/Akt pathway inhibitor 58 CCR9 antagonist 58 Ltd. OTCBB IMUC 58 Tekmira Pharmaceuticals Corporation 58 Serena Mautone 58 targeted anticancer biopharmaceuticals 58 commercializing oxidized glutathione 58 THE EXPRESSED WRITTEN CONSENT 58 injectable polymer 58 active AKT inhibitor 58 oral prodrug 58 Oracea TM 58 NASDAQ PANL enabling 58 FUNDING AS WELL AS 58 manufactures minimally invasive 58 Merck OSI Pharmaceuticals 58 www.facebook.com/pages/OTC-ADVISORS-LLC/#strawberry flavoring 58 www.ilgenetics.com 58 technology visit http:/www.genmab.com 58 MATERIALLY FROM THOSE PROJECTED 58 Polymer Material 58 REGENERX BIOPHARMACEUTICALS INC. 58 THE STATEMENTS WHICH 58 Illusionist Toy Story 58 Inc. NASDAQ MBLX 58 developing Zerenex ferric 58 Prodarsan R 58 MAY DIFFER 58 URGES INVESTORS AND SECURITY 58 PRNewswire FirstCall YM BioSciences 58 vitamin B# uptake 58 www.anthera.com 58 SNOW WILL DEVELOP 58 please visit http:/www.supergen.com 58 Inc. Nasdaq ALNY 58 Telik Announces 58 Genisphere 58 6R BH4 tetrahydrobiopterin naturally 58 BAUKNIGHT 58 vaccine GRNVAC1 58 siRNA binds 58 candidate deforolimus 58 website www.depomed.com 58 Locked Nucleic Acid LNA 58 FoldRx Pharmaceuticals Inc. 58 Pruvel ™ 58 IS DEFINED IN 58 www.isignmedia.com 58 Hematide ™ 58 AND COMPRISES CANOPY PORCH 58 TSX BSY 58 Angiocept 58 REPORTS FILED FROM 58 SANUWAVE Health 58 NOVAVAX 58 www.combinatorx.com 58 predictive toxicology 58 WITHIN THE MEANING OF 58 Note SHIPPING CHARGES 58 INCLUDES FORWARD LOOKING STATEMENTS 58 Balchin HMS Victory 58 CAUTIONARY STATEMENT UNDER 58 orally administered inhibitor 58 aTyr Pharma 58 Symbol MNLU OTCBB 58 highly selective inhibitor 58 Receives Approvable Letter 58 Biomoda www.biomoda.com 58 CD# CEA 58 Fovea Pharmaceuticals subsidiary 58 Hybridon 58 CCR2 receptor 58 NORTHERN CONNECTICUT 58 Pentad TM 58 THe ORIGINAL CREDITOR WITHIN 58 HISTORICAL ARE FORWARD LOOKING 58 www.twitter.com shamrockstocks -www.shamrockstocks.com About 58 Azedra TM Onalta TM 58 INVESTORS ARE CAUTIONED AGAINST 58 using ImmunoGen TAP 58 c Raf kinase 58 multi kinase inhibitor 58 CONTAINS CERTAIN FORWARD LOOKING 58 Initiates Phase III 58 endosomal release 58 Adamis Viral Therapies 58 Inc. Nasdaq AVRX 58 SUBSTANTIAL SHELTER 58 NEVADO RESOURCES CORPORATION 58 PLACE UNDUE RELIANCE UPON 58 THE RISKS SHOWN 58 ACTUAL RESULTS COULD DIFFER 58 Corporation OTCBB SVUL 58 AMEX INO 58 BiTE R 58 GLOBE NEWSWIRE LTX Credence 58 Zemiva ™ 58 Receives Orphan Drug 58 STATEMENTS AND 58 Phenomix Corporation 58 website www.aeroflex.com 58 Æterna Zentaris Inc. 58 OTCBB PRTX 58 Novosom 58 VEGFR2 inhibitor 58 CAUTIONED NOT TO 58 mysunshinecoast.com.au may 58 novel MetAP 2 58 Isis# where 58 anti infective treatments 58 website http:/www.depomed.com 58 OTCBB VCRT 58 Nasdaq OMER 58 www.medicago.com 58 BY BILL McGRAW 58 EZchip Semiconductor Nasdaq EZCH 58 Amex PTN 58 Receives Fast Track 58 VERBINDLICH IST AUSSCHLIESSLICH DIE 58 www.adeonapharma.com 58 targeted radiotherapeutic 58 Initiates Clinical 58 OTC BB PVCT http:/www.pvct.com 58 Corporation Nasdaq CRGN 58 Amex KAL 58 BY SUCH FORWARD 58 Protein Kinase C 58 www.cytomedix.com 58 IBPM 58 REGULATORY AUTHORITY HAS APPROVED 58 Inc. Nasdaq SUPG 58 OR DISAPPROVED THE 58 OTCBB PYTO FWB ET6 58 Protein Polymer Technologies 58 vaccines oncolytic virus 58 metabolism viral replication 58 biologic therapeutics 58 A3 adenosine receptor 58 Medarex logo 58 developing ACAPODENE 58 http:/www.curagen.com 58 genomics proteomics cellular 58 potently inhibit 58 express Luminex 58 developing adecatumumab 58 OF THESE SECURITIES 58 AVEO Pharmaceuticals Inc. 58 nano particle tumor suppressor 58 molecular imaging radiopharmaceuticals 58 adrenergic regulation 58 Achieves Primary Endpoint 58 registered trademark Reg 58 hyaluronidase enzyme 58 http:/www.ariad.com 58 commercial bioproduction 58 Nanobody R 58 Brussels THR 58 International www.iscointl.com 58 alpha folate receptor 58 AMONG OTHERS INVESTORS ARE 58 INFORMATION CONTAINED HEREIN 58 OTCBB INSV 58 Alseres Cethrin 58 www.antigenexpress.com 58 Viprovex TM 58 Gorzno Poland 58 TRACON Pharmaceuticals 58 evaluating intravenous picoplatin 58 impart lubricity prohealing 58 Oxis International 58 www.palatin.com 58 Akebia Therapeutics 58 http:/www.celgene.com 58 DEV DA TOMAR NEXT 57 OTCBB NVLT biopharmaceutical 57 OTCBB PVSP 57 Adenosine Therapeutics 57 AVANIR Pharmaceuticals Inc. 57 Tezampanel 57 NOT RAISED BELOW 57 Nasdaq ALNY 57 5 HT6 57 Protalex Inc. 57 SNALP technology 57 FUTURE RESULTS 57 AEMD 57 http:/www.memorypharma.com 57 TSX ONY 57 AND FUTURE EVENTS 57 mda 7 57 Pharming website http:/www.pharming.com 57 mso padding alt 0cm 57 www.lca vision.com 57 Novel Antibody 57 Surfactant Technology 57 sulfonylhydrazine class 57 products MKC# PP 57 David Pilbeam curator 57 MKC# MT 57 novel antibody therapeutics 57 oncology therapeutics 57 near Schefferville Quebec 57 OmniComm intends 57 OR NATURE 57 Phase #b/#a clinical 57 Euronext Paris Code Isin 57 INVESTORS ARE CAUTIONED NOT 57 LAW MSCI 57 orally bioavailable mimics 57 DESCRIBED IN THE 57 Through Glycoscience R 57 non nucleoside HCV 57 including HGF ErbB3 57 Petit Couronne France 57 Send editorials 57 YOUR STOCKBROKER OR OTHER 57 transformed peptic ulcer 57 Potassium Chloride Sodium Ascorbate 57 y h 57 oral Janus kinase 57 TSX VENTURE ZMS FRANKFURT 57 proprietary biomaterials 57 NASDAQ PRAN ASX PBT 57 Myrexis Inc. 57 symbol AVXL 57 Submits IND 57 CORLUX CORT # 57 Worldwide TopQuadrant Trivera Technologies 57 TB4 mechanisms 57 http:/www.marinabio.com 57 pharmacogenomic translational research 57 bio therapeutics 57 www.spectrumpharm.com 57 OTCBB DLYT 57 small molecule thrombopoietin 57 http:/www.pharmion.com 57 protein tyrosine phosphatase 1B 57 Nasdaq ENZN 57 RECOTHROM ® 57 Receives Orphan Drug Designation 57 sanofi aventis Bayer Schering 57 tiapamil 57 Oncolytics please 57 Palatin Technologies website 57 THE COMPANY 'S STRATEGIES 57 Inc. Nasdaq INFI 57 http:/www.sangamo.com/ 57 OTCBB AUGT 57 Arcelis ™ 57 MEK Inhibitor 57 metabolite identification 57 THROUGH HIS 57 reversible inhibitor 57 WILL PROVE TO BE 57 dermatology therapies 57 Sphingomab TM 57 http:/www.vical.com 57 RONDEL ™ 57 KL4 Surfactant 57 SinuNase ™ 57 Onalta 57 PRNewswire FirstCall Senomyx 57 MYBA Announces Acquistion 57 rumpled dresser 57 Osisko Releases 57 www.epixpharma.com 57 NASDAQ INGN 57 YOUR OWN BLOG AD 57 Panzem R 57 P#X# antagonist 57 markets HP Acthar 57 Nasdaq IDIX 57 developing Surfactant Replacement 57 Kambayashi File 57 HISTORICAL FACT ARE FORWARD 57 DYMTF 57 OTCBB FCSC biotechnology 57 HCV NS5B polymerase 57 RoseStreet Labs Energy 57 http:/www.nabi.com 57 ENTB 57 asthma COPD Chronic 57 www.pharsight.com 57 IMiDs R 57 DiLA2 Platform 57 Hemopurifier ® captures 57 IN SOME CASES 57 UNITED STATES SECURITIES ACT 57 ThinkFree Thinwire TIBCO TMP 57 visit biotech.com 57 EPIX Pharmaceuticals 57 microsurgical disciplines 57 immunotherapeutics 57 Kinase Inhibitor 57 romazarit 57 Company website www.anormed.com 57 NOxOUT ULTRA R 57 Free apologetics 57 evaluating satraplatin 57 Applied NeuroSolutions 57 XML UDDI Universal 57 KRYSTEXXA TM pegloticase 57 DCSW# DCSW# 57 Wachigabau property 57 Two Upcoming Investor 57 Devout Hindus believe 57 www.vivakor.com 57 visit www.oncolyticsbiotech.com 57 evaluating bafetinib 57 HGS ETR1 mapatumumab 57 auristatin E MMAE 57 angiotensin analog 57 CORTOSS R 57 NOxOUT ® NOxOUT CASCADE 57 EXPECTED RESULTS MAY INCLUDE 57 Inc. PINKSHEETS FWDG 57 therapeutic monoclonal antibody 57 Inhaling steam 57 website www.internationalstemcell.com 57 RAF kinase VEGFR 57 visit www.sciclone.com 57 ALL PACKING & 57 Matt Kenseth Truex 57 EWING NJ Business Wire 57 AT HTTP :/ 57 WHATSOEVER WITH RESPECT TO 57 Mutlaq Mahmoud 57 Ep CAM 57 Paris EURONEXT SAN 57 ABOVE YOUR RIGHTS 57 Earns Milestone Payment 57 www.achillion.com 57 NASDAQ CVV 57 HCV polymerase inhibitors 57 LOW PRICE STOCK 57 www.micromet inc.com 57 Enable IPC Corporation 57 MP4 molecule 57 ENTIRETY BECAUSE THEY CONTAIN 57 Atripla combines 57 READERS SHOULD NOT 57 RAS MAPK pathway 57 WHY ACTUAL RESULTS COULD 57 poly ADP ribose polymerase 57 www.dyadic.com 57 myelofibrosis polycythemia vera 57 www.pernixtx.com 57 3 kinase PI3K 57 Avila Therapeutics 57 Inc. http:/www.modavox.com 57 Tripos logo 57 OTCBB CTIX 57 pan HDAC inhibitor 57 targeted immunotherapies 57 Pixelplus cautions readers 57 immunotherapies 2A/Furin 57 telomerase inhibitor drug 57 TSX AMB 57 developing TB4 56 ARE USED THEY IDENTIFY 56 www.targacept.com 56 proteomics bioinformatics 56 e h r 56 EWING NJ BUSINESS WIRE 56 Aeolus Pharmaceuticals Announces 56 Ceragenix Pharmaceuticals Inc. 56 Aganocide 56 hepatitis C polymerase 56 TSX AHX 56 pathophysiological effects 56 Enterobacter spp 56 concerning Aeroflex Incorporated 56 Novel Antibiotic 56 estrogen receptor beta agonist 56 www.ariad.com 56 www.facebook.com/pages/OTC-ADVISORS-LLC/#veejay 56 OR ACCURACY OF 56 Nasdaq CRXL 56 VIA Pharmaceuticals 56 engineered proteases 56 Fibroblast Growth Factor Receptor 56 SHAREHOLDERS CONCERNING FORWARD LOOKING 56 methylation markers 56 TO PLACE UNDUE 56 Anti Tumor 56 allosteric modulation 56 superior bioprocessing 56 Sangamo BioSciences Inc. 56 candidate AQ4N 56 biomimetics non 56 IN MANAGEMENT 'S 56 provides BioMaterial GenoTyping ™ 56 SECTION #A OF 56 http:/www.ovonic.com 56 N acetylgalactosamine 6 56 AP Photo DCLJ# 56 Myolimus 56 Pain Neutralizer holds 56 website www.novavax.com 56 Bioral Amphotericin B. 56 Zalypsis 56 S ROSE HILL 56 HepDirect R 56 Hsp# Inhibitor 56 MULLIGAN FAMILY FUN CENTER 56 www.entechsolar.com 56 www.implantsciences.com 56 novel antimitotic agent 56 initiated Phase 1b 56 Initiates Phase 2b 56 Etubics 56 Trofex ™ 56 NNAN 56 Gulls pelicans roseate spoonbills 56 Ostarine ™ 56 neuronal nicotinic receptor NNR 56 www.nanoviricides.com 56 liposomal delivery 56 ENMD # 56 Amends Private Placement 56 multivalency toward drug 56 RISKS ASSOCIATED WITH 56 elicits ribbit 56 please visit www.goldenhopemines.com 56 TSX VENTURE RM OTCQX 56 Mg Usa 56 Oral Calcitonin 56 Prana Biotechnology Limited 56 Powerwave logo 56 TLR9 agonists 56 malignant mesothelioma Alfacell 56 visit www.accelrys.com 56 IS NOT BEING MADE 56 www.sangamo.com 56 please visit http:/www.globalaxcess.biz 56 Cobalamin TM mediated 56 ® NOxOUT ULTRA 56 TSX YM AIM 56 Rigel R# 56 WTWO Quote Chart News 56 selective inhibition 56 UNITED STATES PRIVATE SECURITIES 56 Jens Vellev professor 56 SMARTICLES ® 56 www.combimatrix.com 56 OMRIX Biopharmaceuticals Inc. 56 markets COLAZAL 56 Aerie Pharmaceuticals 56 pharmacological chaperone 56 THE TIME PROVIDED 56 AMEX RGN 56 NasdaqGM SPPI 56 AMENDMENT OF 56 Submits Biologics License Application 56 anti miRs antisense oligonucleotide